o C. The arteries were examined using a 30-MHz transducer and Vevo 2100 ultrasound system (Visual Sonics, Toronto, ON, Canada). The angle between the ultrasound probe and the direction of the flow was kept at less than 50 degrees (33 degrees on average) during the recordings of the velocity waveforms. The velocities of the main uterine arteries were recorded below the bladder and at the level where the main uterine artery branches from the internal iliac artery. Peak systolic velocity (PSV) and enddiastolic velocity (EDV), the area under the peak velocity-time curve, and R-R interval were measured from 3 consecutive cardiac cycles and the results were averaged. Uterine artery luminal (ie, inner) diameter was measured from B-mode images and confirmed by micro-CT and myograph studies. 2 Mean velocity (MV) over the cardiac cycle was calculated by dividing the area under the peak velocity-time curve by the R-R interval. Blood flow velocity distribution was determined using the following formula: 
Placental vascularization
Uteroplacental vascularization: Uteroplacental vascularization was performed using silicon rubber-based x-ray contrasting agent infusion as per the previously established methods.
3 In brief, under isoflurane anesthesia, heparin (0.5 mL of 600IU/mL) and xylocaine (0.5 ml of 2% xylocaine) was injected into the beating heart and allowed to circulate for a minute. A catheter inserted into the descending thoracic aorta was first used to clear blood from lower body vasculature using pump-infused heparinized saline containing xylocaine (1% wt/v). Then, the contrast agent (MV-122 Microfil, Flow Tech Inc., Carver, MA) was infused until 5 minutes after the contrast agent first started flowing out through the vented vena cava. The vena cava was ligated to maintain pressure and the silicone rubber-based contrast agent was allowed to polymerize for 45 minutes. After polymerization of the casting compound at 4°C, placentas were dissected along with major uterine arteries and stored in 10% (v/v) formalin.
Fetoplacental vascularization: Pregnant rats were sacrificed by carbon dioxide inhalation, and their uteri were placed into ice-cold phosphate buffered saline. One by one, the conceptuses were surgically exposed and warmed to resume circulatory function. A cannula inserted into the umbilical artery was first used to clear blood from the vasculature using heparinized saline containing xylocaine, 3 and then the contrast agent (MV-122 Microfil) was manually infused until it was seen entering the capillary bed. The umbilical vessels were ligated to maintain pressure during polymerization. The umbilical cord was then severed and the placentas were immersed in formalin (10% v/v) and later mounted in agar (1%) for micro-CT imaging.
The cast placentas were staged and scanned in a MS-9 micro-CT scanner (Siemens Preclinical Solutions, Knoxville, TN) as previously described. 4 The camera and detector were rotated 360° around the horizontal axis, generating 720 views that were subsequently reconstructed into data blocks with a 13 μm voxel size. Vascular surface visualizations were generated from micro-CT data to visualize the arterial vasculature as previously described. 4 The DICOM files generated from the micro-CT scan were imported and skeletonized to create rendered volumes of the specimens. The raw data files were oriented and cropped using the Amira software package (Visage Imaging, San Diego, CA) as previously described. 5 The files were converted into a compatible file format amenable for segmentation. The software was used to create spatial and attribute graphs. Uteroplacental vascular trees were segmented into spiral arteries and maternal canals. The span and depth of the fetoplacental arterial tree were measured, and the number of branching generations in each fetoplacental arterial specimen was determined in a downstream direction from the umbilical artery as previously described. 5 Calipers in the software were used to measure diameters and lengths of region of interest. Diameters were measured at 3 or more sites along the imaged segment, and at 15 or more sites along the longer and more tortuous spiral arteries. Measurements for each vessel type were then averaged for each specimen examined. Measurements from 2 placentas per sex per dam were averaged (n=6 in each group).
Assessment of placental and fetal hypoxia 1) Pimonidazole was injected intraperitoneally in the rats at day 20 of gestation (60 mg/kg maternal body wt). One hour later, the mother was euthanized, and placentas and fetal livers were isolated and processed for Western blotting and probed for hypoxyprobe-1 following the manufacturer's protocol. 6;7 Hypoxia were identified using a Hypoxyprobe-1TM kit (Chemicon, Temecula, CA; cat. no. HP1-100kit) that contains pimonidazole hydrochloride and a primary antibody for the detection of pimonidazole. Pimonidazole binds to thiol-containing proteins in hypoxic cells; its level in the cells has been correlated with oxygen electrode measurements. 8 2) HIF-1α is a transcription factor that is increased under hypoxic conditions. 9 Western blotting for HIF-1α (1:1000 antibody dilution, Abcam, San Francisco, CA) was performed on placentas and fetal livers as previously described.
2 Densitometric measurement was done using AlphaEase FluorChem 8000 software (Alpha Innotech, Santa Clara, CA). Results were expressed as ratios of band intensity to that of β-actin.
Placental and fetal sex determination
Males were determined by the presence of the Sry gene in genomic DNA with 1 microgram DNA template added in polymerase chain reactions (PCR) and females by no Sry gene amplification as described by us. 10 Briefly, genomic DNA was extracted from frozen fetal membranes or tails of male and female fetuses with DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA), and all procedures were performed according to the instruction manual. The sequence of forward primers for the Sry gene was 5'-cacaagttggctcaacagaatc-3' and reverse primer 5'-agctctactccagtcttgtccg-3'. One microgram genomic DNA from adult males and females was included as either a positive or negative control for the PCR procedure. PCR conditions were as follows: 1) 94°C for 5 minutes; 2) 94°C for 1 minutes, 54°C for 2.5 minutes, and 72°C for 1 minutes for 36 cycles; and 3) 72°C for 7 minutes. The PCR products were analyzed by agarose gel electrophoresis.
Placental gene expression by microarray
RNA isolation was performed using the Rneasy kit (Qiagen) from placentas of both the male and female fetuses in the control group and the T-treated rats (n= 6 in each sex/group). Two micrograms of total RNA was reverse transcribed to double-stranded cDNA using the QuantiTect RT kit (Qiagen). Placental cDNA was then processed for use on the Affymetrix Rat 1.0 array (Affymetrix, Santa Clara, CA) according to the manufacturer's instructions. Briefly, the double-stranded cDNA was used in an in vitro transcription reaction to generate biotinylated cRNA probes. The cRNA probes were purified, fragmented, and hybridized to the Affymetrix chip. Washes and staining were performed in an Affymetrix Gene Chip Fluidic station 400. Then, the Affymetrix arrays were scanned using a Affymetrix GeneChip Scanner 30 (Hewlett Packard, Austin, TX), and raw data .txt files were extracted. Using the GeneSpring GX -Agilent Technologies data were normalized and differentially expressed gene transcripts with Benjamini Hochberg (BH) adjusted statistical significance (P<.05) were identified through Volcano Plot filtering. GO analysis were performed using David functional clustering analysis.
Validation of gene expression by quantitative real-time PCR
To validate the angiogenesis, blood vessel morphogenesis, and vasculature development processassociated genes that are differentially expressed in the microarray, we have designed the gene specific primers for Nos3, Angptl4, Emcn, Edn1, Flt, Cxcr4, Bmp4, Plau, and Il1b were purchased from Integrated DNA Technologies. mRNA from placentas of each male and female fetus in the control group and the T-treated rats were isolated using an Rneasy kit (Qiagen). cDNA was obtained by reverse transcription with an iScript cDNA synthesis kit (Biorad). Using gene-specific primers, qRTPCR was performed using iTaq Universal SyBr green super mix (Biorad). Relative expression was normalized to β-actin, and fold changes were calculated using the 2 -ΔΔCt method.
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